| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 673191 | Null | 0.0273093708703115 | 0.27944958 |
| NSC 685844 | Null | 0.0273093708703115 | -0.071669837 |
| NSC 692655 | D-Homo-17a-aza-5-androsteno[17,16-c]pyrazol-3-yl,2'-(4-fluorophenyl)-, acetate | 0.0273093708703115 | -0.0082494032 |
| NSC 707148 | Card-20(22)-enolide, 3-[(6-deoxy-3-O-methyl-.beta.-D-galacto pyranosyl)oxy]-14-hydroxy-, (3.beta.,5.beta)- (9CI) | 0.0273093708703115 | -0.15725337 |
| NSC 707149 | Card-20(22)-enolide, 16-(acetyloxy)-3-[(6-deoxy-3-O-methyl- .beta.-D-galactopyranosyl)oxy]-14-hydroxy-,(3.beta.,5.beta.,16.beta.)- (9CI) | 0.0273093708703115 | -0.16121586 |
| NSC 716766 | Null | 0.0273093708703115 | -0.047923171 |
| NSC 755302 | 2-methoxy-4-(7-methoxy-2-phenylbenzo[d]imidazo[2,1-b][1,3]thiazol-3-yl)phenol | 0.0273093708703115 | 0.36737715 |
| NSC 756319 | GW694590A | 0.0273093708703115 | 0.33585682 |
| NSC 123491 | L-Cysteine, S-[tris(4-methylphenyl)methyl]- (9CI) | 0.0287337488682928 | 0.22743894 |
| NSC 48006 | WLN: T6N CNJ DZ EF F- BT5OTJ EO1 | 0.0287337488682928 | -0.11598855 |